Stock listing

Munich:Z45 Alvotech Aktie

German listing (Munich) of Alvotech · home listing NASDAQ:ALVO

Follow Alvotech into a list and get an email when it puts out news.

Home listing price · NASDAQ:ALVO

$4.12 USD -0.43 (-9.5%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ALVO

Past year -18.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$4.09 – $4.29 USDNov 20, 2026
Volume
826,571 sharesNov 20, 2026
Market cap
$1.47B USDAt the close on Nov 20, 2026 · price × 356.8M shares outstanding
52-week range
$2.94 – $6.53 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$5.99M USDMedian day 946,927 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Alvotech logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:ALVO · Home$4.12 USD-0.43 (-9.5%)826,571$4.26$4.29$4.09$4.55Close on Nov 20, 2026
Frankfurt:Z45€3.67 EUR-0.17 (-4.4%)—€3.68€3.69€3.67€3.84Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ALVO · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$4.12-0.43-9.5%$4.26$4.29$4.09826,571
$4.55+0.18+4.1%$4.375$4.67$4.351,561,440
$4.37-0.035-0.8%$4.40$4.48$4.211,515,211
$4.405+0.215+5.1%$4.16$4.59$4.151,027,644
$4.19-0.48-10.3%$4.58$4.63$4.1352,091,332
$4.67-0.25-5.1%$4.49$4.76$4.312,990,091
$4.92+0.04+0.8%$4.94$5.03$4.87798,114
$4.88+0.19+4.1%$4.73$4.897$4.665946,927
$4.69-0.17-3.5%$4.89$4.94$4.661,265,280
$4.86+0.31+6.8%$4.57$4.935$4.571,015,933
$4.55-0.12-2.6%$4.66$4.66$4.51752,743
$4.67+0.13+2.9%$4.56$4.765$4.47668,970
$4.54+0.06+1.3%$4.595$4.655$4.481541,365
$4.48-0.17-3.7%$4.75$4.75$4.471,552,224
$4.65-0.24-4.9%$4.85$4.87$4.555714,816
$4.89-0.05-1.0%$4.95$5.00$4.845373,199
$4.94+0.19+4.0%$4.77$4.97$4.735627,901
$4.75+0.13+2.8%$4.62$4.765$4.60733,316
$4.62+0.04+0.9%$4.57$4.635$4.52584,879
$4.58-0.21-4.4%$4.78$4.78$4.565666,200
$4.79-0.34-6.6%$5.07$5.07$4.79926,486
$5.13+0.01+0.2%$5.14$5.24$5.115480,520
$5.12+0.09+1.8%$5.40$5.45$5.0851,302,195
$5.03+0.03+0.6%$5.13$5.15$5.02907,210
$5.00-0.31-5.8%$5.27$5.30$4.951,059,087
$5.31+0.14+2.7%$5.15$5.39$5.1311,156,272
$5.17-0.21-3.9%$5.32$5.51$5.151,058,173
$5.38-0.12-2.2%$5.51$5.64$5.3111,214,000
$5.50-0.28-4.8%$5.79$5.89$5.44841,000
$5.78+0.11+1.9%$5.67$5.805$5.565707,100
$5.67-0.18-3.1%$5.83$5.83$5.605668,900
$5.85-0.29-4.7%$6.10$6.14$5.845864,600
$6.14+0.03+0.5%$6.07$6.17$6.001,218,300
$6.11+0.66+12.1%$5.99$6.53$5.902,898,700
$5.45-0.17-3.0%$5.61$5.70$5.43750,900
$5.62-0.18-3.1%$5.81$5.82$5.461,201,500
$5.80-0.12-2.0%$5.95$5.97$5.761,135,500
$5.92-0.23-3.7%$6.135$6.17$5.8251,169,200
$6.15+0.40+7.0%$5.73$6.17$5.6751,435,700
$5.75-0.13-2.2%$5.90$5.90$5.67705,200
$5.88+0.07+1.2%$5.75$6.06$5.751,198,000
$5.81-0.03-0.5%$5.86$5.89$5.70774,000
$5.84-0.04-0.7%$5.90$5.97$5.715975,900
$5.88+0.01+0.2%$5.92$5.98$5.741,312,300
$5.87+0.53+9.9%$5.40$5.985$5.3953,527,100
$5.34+0.24+4.7%$5.22$5.455$5.201,704,500
$5.10+0.08+1.6%$5.40$5.53$5.103,864,100
$5.02-0.03-0.6%$5.05$5.07$4.90610,000
$5.05-0.24-4.5%$5.225$5.26$5.035674,200
$5.29+0.05+1.0%$5.28$5.39$5.26667,900
$5.24+0.03+0.6%$5.21$5.34$5.14540,900
$5.21+0.02+0.4%$5.15$5.24$5.06572,400
$5.19-0.13-2.4%$5.26$5.32$5.142632,600
$5.32-0.06-1.1%$5.31$5.40$5.205535,400
$5.38+0.04+0.7%$5.37$5.47$5.275673,700
$5.34+0.10+1.9%$5.24$5.415$5.171700,300
$5.24+0.05+1.0%$5.08$5.265$4.981,028,900
$5.19+0.24+4.8%$5.00$5.265$4.981,250,700
$4.95+0.07+1.4%$4.84$5.00$4.82878,300
$4.88-0.03-0.6%$4.88$4.979$4.785967,700
$4.91-0.14-2.8%$4.98$4.99$4.782890,000
$5.05-0.20-3.8%$5.24$5.39$5.0151,771,959
$5.25+0.82+18.5%$4.79$5.359$4.7153,178,120
$4.43+0.16+3.7%$4.32$4.595$4.322,268,900
$4.27+0.28+7.0%$3.89$4.37$3.751,370,300
Ticker
Munich:Z45
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Munich
Currency
EUR

What changed lately

Latest news

All Alvotech news

Alvotech on 6ix

Sector
Health care
Industry
Biotechnology
News releases
49 in the last 12 months · 224 in all · newest Nov 11, 2026 · oldest 2022
Calls
18 calls with a replay · 18 with a transcript · latest Nov 12, 2026
Decks
12 decks · latest Nov 12, 2026

Where Alvotech is listed

ListingExchangeCountryCurrency
NASDAQ:ALVO · Home listingNASDAQUnited StatesUSD
OMXICE:ALVOOMXICEIcelandISK
Stockholm:ALVOSDBStockholmSwedenSEK
LS Exchange:A3DK8ULS ExchangeGermanyEUR
Lang & Schwarz:A3DK8ULang & SchwarzGermanyEUR
gettex:Z45gettexGermanyEUR
Frankfurt:Z450FrankfurtGermanyEUR
BX Swiss:ALVOBX SwissSwitzerlandCHF
BOATS:ALVOBOATSUnited StatesUSD
Dusseldorf:Z450DusseldorfGermanyEUR
Frankfurt:Z45FrankfurtGermanyEUR
Munich:Z45 · This pageMunichGermanyEUR
Stuttgart:Z45StuttgartGermanyEUR
BX Swiss:ALVOUSDBX SwissSwitzerlandUSD
Dusseldorf:Z45DusseldorfGermanyEUR
Hamburg:Z45HamburgGermanyEUR
Turquoise:ALVOSTurquoiseUnited KingdomSEK

Valuation

EV/sales 5.7× against a median of 15.5×: 3rd lowest of 8 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$2.78B USD
P/E
Loss
EV/sales
5.7×
EV/EBITDA
31.4×
Price/book
Negative equity
Gross margin
60.5%
Operating margin
9.6%
Net margin
−36.5%
Debt to equity
Negative equity
Beta vs S&P 500
0.90

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Alvotech · NASDAQ:ALVOUS$1.47BUS$2.78Bn/a5.7×31.4×n/a−36.5%n/a0.90
Recursion Pharmaceuticals, Inc. · NASDAQ:RXRXUS$1.53BUS$987.7Mn/a14.5×n/a1.7×−697.1%0.0×2.83
ABL Bio, Inc. · KRX:298380US$1.47BUS$1.34Bn/a52.7×n/a11.5×−229.4%0.0×n/a
PELL Bio-Med Technology Co Ltd · TWSE:6949US$1.46BUS$1.40Bn/a1,591×n/a18.7×n/a0.1×n/a
Mesoblast Limited · ASX:MSBUS$1.46BUS$1.42Bn/a82.4×n/a2.4×−593.9%0.2×n/a
Damora Therapeutics, Inc. · NASDAQ:DMRAUS$1.44BUS$910.0Mn/an/an/a2.9×n/a0.0×0.88
Vir Biotechnology, Inc. · NASDAQ:VIRUS$1.44BUS$1.07Bn/a3.5×n/a1.6×−61.0%0.1×1.82
Voronoi, Inc. · KRX:310210US$1.44BUS$1.39Bn/an/an/a27.9×n/a0.5×n/a
Kailera Therapeutics, Inc. · NASDAQ:KLRAUS$1.43BUS$539.5Mn/an/an/a1.4×n/a0.0×1.28
Sarepta Therapeutics, Inc. · NASDAQ:SRPTUS$1.43BUS$1.41Bn/a0.7×n/a0.9×−5.9%0.6×1.70
LigaChem Biosciences Inc. · KRX:141080US$1.42BUS$1.14Bn/a15.5×n/a4.8×−180.9%0.0×n/a
Median of the othersUS$1.44BUS$1.24B15.5×2.7×−205.1%0.1×1.70

Forecasts

3 strong buy · 2 buy · 1 hold · Analysts' consensus from EODHD, read Nov 13, 2026. Not 6ix's view and not investment advice.

Price target
7.50 USD · Analysts' mean
EPS, year to Dec 2026
-0.036 · 4 analysts
Revenue, year to Dec 2026
652.3M · 6 analysts

Team and board

Officers

OfficerRole
Lisa GraverChief Executive Officer
Linda JónsdóttirChief Financial Officer
Joseph E. McClellanChief Operating Officer
Benedikt StefanssonVP Investor Relations and Global Communications IS
MediaBenedikt StefanssonVP Investor Relations and Global CommunicationsSarah Macleod, Head of Global
Patrik LingVP of Investor Relations Scandinavia
Kathryn GunnarssonSVP Global Talent & People Experience
Anthony M. MaffiaChief Quality and Regulatory Affairs Officer
Balaji PrasadChief Strategy Officer
Neha PatelChief Information Officer
Robert WessmanExecutive Chairman

Board

DirectorRole
Robert WessmanExecutive Chairman

Events

Calls

CallWhenStatus
Alvotech (NASDAQ:ALVO) Q3 2026 Earnings CallThu, Nov 12, 2026 · 8:00 AM ETReplay
Alvotech (NASDAQ:ALVO) Q2 2026 Earnings CallThu, Aug 20, 2026 · 8:00 AM ETReplay
Alvotech (NASDAQ:ALVO) Q1 2026 Earnings CallThu, May 07, 2026 · 8:00 AM ETReplay
Alvotech (NASDAQ:ALVO) Q4 2025 Earnings CallThu, Mar 19, 2026 · 8:00 AM ETReplay
Alvotech (NASDAQ:ALVO) Q3 2025 Earnings CallThu, Nov 13, 2025 · 8:00 AM ETReplay
Alvotech (NASDAQ:ALVO) Q2 2025 Earnings CallThu, Aug 14, 2025 · 8:00 AM ETReplay
Alvotech (NASDAQ:ALVO) Q1 2025 Earnings CallThu, May 08, 2025 · 8:00 AM ETReplay
Alvotech (NASDAQ:ALVO) Q4 2024 Earnings CallThu, Mar 27, 2025 · 8:00 AM ETReplay
Alvotech (NASDAQ:ALVO) Q3 2024 Earnings CallThu, Nov 14, 2024 · 8:00 AM ETReplay
Alvotech (NASDAQ:ALVO) Q2 2024 Earnings CallFri, Aug 16, 2024 · 8:00 AM ETReplay
All 18 calls
CallWhenStatus
Alvotech (NASDAQ:ALVO) Q1 2024 Earnings CallWed, May 22, 2024 · 8:00 AM ETReplay
Alvotech (NASDAQ:ALVO) Q4 2023 Earnings CallThu, Mar 21, 2024 · 8:00 AM ETReplay
Alvotech (NASDAQ:ALVO) Q3 2023 Earnings CallWed, Nov 29, 2023 · 8:00 AM ETReplay
Alvotech (NASDAQ:ALVO) Q2 2023 Earnings CallThu, Aug 31, 2023 · 8:00 AM ETReplay
Alvotech (NASDAQ:ALVO) Q1 2023 Earnings CallFri, May 19, 2023 · 8:00 AM ETReplay
Alvotech (NASDAQ:ALVO) Q4 2022 Earnings CallThu, Mar 02, 2023 · 8:00 AM ETReplay
Alvotech (NASDAQ:ALVO) Q3 2022 Earnings CallWed, Nov 16, 2022 · 8:00 AM ETReplay
Alvotech (NASDAQ:ALVO) Q2 2022 Earnings CallThu, Sep 01, 2022 · 8:00 AM ETReplay

Results days

QuarterResultsShare move
Quarter to Sep 30, 2026Nov 11, 2026 · After close−5.1%
Q2 2026Aug 19, 2026 · After close+7.0%
Q1 2026May 5, 2026 · After close+2.0%
Q4 2025Mar 18, 2026−6.3%
Q3 2025Nov 12, 2025 · After close−1.4%
Q2 2025Aug 13, 2025 · After close−5.4%
Q1 2025May 7, 2025+17.7%
Q4 2024Mar 26, 2025 · After close−10.3%
Q3 2024Nov 13, 2024 · After close+1.2%
Q2 2024Aug 15, 2024 · After close+8.7%
All 20 quarters
QuarterResultsShare move
Q1 2024May 21, 2024 · After close+0.4%
Q4 2023Mar 20, 2024 · After close−1.1%
Q3 2023Nov 28, 2023 · After close−4.1%
Q2 2023Aug 30, 2023 · After close+1.8%
Q1 2023May 19, 2023 · Before open+0.6%
Q4 2022Mar 1, 2023 · After close+0.8%
Q3 2022Nov 15, 2022 · After close+4.3%
Q2 2022Aug 31, 2022 · After close−14.3%
Q1 2022May 16, 2022 · After close0.0%
Q4 2021Mar 30, 2022 · After close+0.3%

Open Events

Decks

DeckKindSlidesDate
9M 2026 Earnings PresentationEarnings31 slidesNov 12, 2026
H1 2026 Earnings PresentationEarnings31 slidesAug 20, 2026
Q1 2026 Earnings PresentationEarnings21 slidesMay 7, 2026
FY2025 Earnings PresentationEarnings19 slidesMar 19, 2026
FY2025 Earnings PresentationEarnings36 slidesMar 19, 2026
Q3 2025 Earnings PresentationEarnings23 slidesNov 13, 2025
Q2 2025 Earnings PresentationEarnings12 slidesAug 14, 2025
SPAC Merger (May 2022)SPAC merger80 slidesMay 17, 2022
Oaktree Acquisition Corp. II — SPAC Merger (March 2022)SPAC merger84 slidesMar 23, 2022
SPAC Merger (March 2022)SPAC merger84 slidesMar 23, 2022
All 12 decks
DeckKindSlidesDate
SPAC Merger (February 2022)SPAC merger64 slidesFeb 15, 2022
SPAC Merger (December 2021)SPAC merger62 slidesDec 7, 2021

Open Decks

Financings

RaiseDateIn US dollars
Public offering of ordinary shares
Closed: US$98M raised · US$3.75 a share · BofA Securities +2
Dealers: BofA Securities (co-lead), Jefferies (co-lead), Evercore ISI (co-lead)
Use of proceeds: Continued development of biosimilar assets, working capital and general corporate purposes
Jun 18, 2026
Private placement of ordinary shares
Announced: about US$67M · US$3.75 a share
Use of proceeds: Continued development of biosimilar assets, working capital and general corporate purposes
Jun 18, 2026
Senior unsecured convertible bonds due 2030
Made bigger: US$108M · DNB Carnegie
Dealers: DNB Carnegie (lead)
Use of proceeds: Continued investment in the R&D pipeline, scaling up production and global product launches.
Dec 17, 2025
Private placement of sDRs and ordinary shares
Closed: DNB Carnegie Investment Bank AB (publ) +3
Dealers: DNB Carnegie Investment Bank AB (publ) (co-lead), Citigroup Global Markets Limited (co-lead), Skandinaviska Enskilda Banken AB (publ) (co-lead), ACRO Securities HF (co-lead)
Use of proceeds: Accelerate R&D activities, especially in Sweden after the Xbrane R&D acquisition, expand pipeline, and general corporate purposes
Jun 11, 2025
Public offering of swedish Depository Receipts (SDRs)
Update: about SEK 39M · SEK 87.51 a receipt · DNB Markets, a part of DNB Bank ASA, Sweden Branch +2
Dealers: DNB Markets, a part of DNB Bank ASA, Sweden Branch, Carnegie Investment Bank, DNB Carnegie Investment Bank AB (publ)
May 19, 2025US$3.99M

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue586.3M489.7M91.4M83.0M36.8M66.6M31.9M
Cost of revenue235.6M185.3M160.9M64.1M00
Gross profit350.8M304.4M-69.4M18.9M36.8M66.6M31.9M
Research and development184.2M171.3M210.8M180.6M191.0M148.1M95.6M
Selling, general and administrative90.9M61.5M73.0M186.7M84.1M58.9M48.6M
Operating income78.2M69.6M-354.9M-346.4M-235.5M-137.5M-61.4M
Depreciation and amortization37.9M31.3M24.2M20.4M18.2M16.4M14.6M
EBITDA116.1M100.9M-330.6M-326.0M-217.3M-121.1M-46.8M
Interest expense149.2M303.2M267.2M188.4M117.4M161.6M95.8M
Income before tax136.3M-217.6M-651.0M-551.6M-149.2M-291.8M-209.4M
Income tax108.4M14.3M-99.3M-38.1M-47.7M-121.7M491.0K
Net income27.9M-231.9M-551.7M-513.6M-101.5M-170.0M-209.9M
Earnings per share, basic0.10-0.87-2.43-2.60-0.92-1.82-0.86
Earnings per share, diluted0.10-0.87-2.43-2.60-0.92-1.82

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents172.4M51.4M11.2M66.4M17.6M31.7M
Receivables69.7M160.2M41.3M33.0M29.4M33.1M
Inventory220.1M127.9M74.4M71.5M39.1M9.65M
Current assets574.0M455.0M194.8M230.7M119.8M86.2M
Property, plant and equipment356.4M284.5M236.8M220.6M78.5M177.0M
Goodwill12.8M11.3M12.1M11.6M12.4M13.4M
Total assets1.49B1.22B950.1M828.4M598.0M474.4M
Accounts payable126.1M67.1M80.6M49.2M28.6M12.0M
Current liabilities304.1M193.4M260.9M167.3M111.8M51.0M
Long-term debt1.26B1.04B922.1M744.7M398.1M565.4M
Total debt1.30B1.07B960.2M764.6M400.9M567.9M
Total liabilities1.77B1.63B1.88B1.39B733.6M1.34B
Shareholders' equity-284.5M-412.8M-932.5M-564.4M-135.6M-867.2M
Shares outstanding312.0M301.8M266.8M252.2M893.1K31.3M243.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-50.2M-236.8M-312.2M-312.4M-228.2M-74.3M-88.5M
Capital spending-64.5M-53.7M-33.2M-37.9M-20.5M-7.49M-8.05M
Free cash flow-114.7M-290.5M-345.4M-350.3M-248.6M-81.8M-96.6M
Cash from investing-104.2M-18.9M-46.3M-63.5M-40.6M-16.9M-12.9M
Cash from financing270.8M297.3M301.3M424.9M254.8M55.4M116.4M
Dividends paid000000
Share buybacks-9.80M
Change in cash116.4M41.6M-57.2M49.0M-14.0M-35.8M15.2M

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G · Big-stake noticeNov 16, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerNov 12, 2026Current reportSEC
6-K · Report of a foreign issuerOct 20, 2026Current reportSEC
6-K · Report of a foreign issuerOct 14, 2026Current reportSEC
6-K · Report of a foreign issuerOct 7, 2026Current reportSEC
6-K · Report of a foreign issuerOct 5, 2026Current reportSEC
6-K · Report of a foreign issuerAug 31, 2026Current reportSEC
6-K · Report of a foreign issuerAug 21, 2026Current reportSEC
6-K · Report of a foreign issuerAug 19, 2026Current reportSEC
6-K · Report of a foreign issuerJul 29, 2026Current reportSEC
Show 200 filings
FilingDateTypeFiled with
6-K · Report of a foreign issuerJul 1, 2026Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedJun 30, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerJun 18, 2026Current reportSEC
6-K · Report of a foreign issuerJun 16, 2026Current reportSEC
424B5 · ProspectusJun 16, 2026Offer documentSEC
FWP · Free writing prospectusJun 16, 2026Offer documentSEC
FWP · Free writing prospectusJun 15, 2026Offer documentSEC
424B5 · ProspectusJun 15, 2026Offer documentSEC
6-K · Report of a foreign issuerJun 15, 2026Current reportSEC
6-K · Report of a foreign issuerJun 8, 2026Current reportSEC
6-K · Report of a foreign issuerJun 4, 2026Current reportSEC
6-K · Report of a foreign issuerMay 11, 2026Current reportSEC
6-K · Report of a foreign issuerMay 4, 2026Current reportSEC
20-F · Annual reportMar 30, 2026Annual reportSEC
6-K · Report of a foreign issuerMar 19, 2026Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 12, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerFeb 27, 2026Current reportSEC
6-K · Report of a foreign issuerFeb 5, 2026Current reportSEC
6-K · Report of a foreign issuerFeb 2, 2026Current reportSEC
6-K · Report of a foreign issuerJan 29, 2026Current reportSEC
6-K · Report of a foreign issuerJan 7, 2026Current reportSEC
6-K · Report of a foreign issuerJan 7, 2026Current reportSEC
6-K · Report of a foreign issuerJan 6, 2026Current reportSEC
6-K · Report of a foreign issuerJan 2, 2026Current reportSEC
6-K · Report of a foreign issuerDec 23, 2025Current reportSEC
6-K · Report of a foreign issuerDec 19, 2025Current reportSEC
6-K · Report of a foreign issuerDec 17, 2025Current reportSEC
6-K · Report of a foreign issuerNov 24, 2025Current reportSEC
6-K · Report of a foreign issuerNov 20, 2025Current reportSEC
6-K · Report of a foreign issuerNov 17, 2025Current reportSEC
6-K · Report of a foreign issuerNov 12, 2025Current reportSEC
6-K · Report of a foreign issuerNov 6, 2025Current reportSEC
6-K · Report of a foreign issuerNov 3, 2025Current reportSEC
6-K · Report of a foreign issuerOct 22, 2025Current reportSEC
6-K · Report of a foreign issuerOct 6, 2025Current reportSEC
6-K · Report of a foreign issuerSep 22, 2025Current reportSEC
6-K · Report of a foreign issuerAug 13, 2025Current reportSEC
UPLOAD · Letter from the SECAug 7, 2025Other filingsSEC
CORRESP · Letter to the SECJul 31, 2025Other filingsSEC
F-3ASRJul 28, 2025Other filingsSEC
6-K · Report of a foreign issuerJul 28, 2025Current reportSEC
UPLOAD · Letter from the SECJul 21, 2025Other filingsSEC
6-K · Report of a foreign issuerJul 10, 2025Current reportSEC
6-K · Report of a foreign issuerJul 9, 2025Current reportSEC
6-K · Report of a foreign issuerJul 1, 2025Current reportSEC
6-K · Report of a foreign issuerJun 25, 2025Current reportSEC
6-K · Report of a foreign issuerJun 23, 2025Current reportSEC
6-K · Report of a foreign issuerJun 12, 2025Current reportSEC
6-K · Report of a foreign issuerJun 11, 2025Current reportSEC
6-K · Report of a foreign issuerJun 5, 2025Current reportSEC
6-K · Report of a foreign issuerMay 28, 2025Current reportSEC
6-K · Report of a foreign issuerMay 27, 2025Current reportSEC
6-K · Report of a foreign issuerMay 9, 2025Current reportSEC
6-K · Report of a foreign issuerMay 8, 2025Current reportSEC
6-K · Report of a foreign issuerMay 7, 2025Current reportSEC
6-K · Report of a foreign issuerMay 5, 2025Current reportSEC
6-K · Report of a foreign issuerMar 27, 2025Current reportSEC
20-F · Annual reportMar 27, 2025Annual reportSEC
6-K · Report of a foreign issuerMar 26, 2025Current reportSEC
6-K · Report of a foreign issuerMar 26, 2025Current reportSEC
6-K · Report of a foreign issuerMar 20, 2025Current reportSEC
6-K · Report of a foreign issuerMar 18, 2025Current reportSEC
6-K · Report of a foreign issuerFeb 24, 2025Current reportSEC
6-K · Report of a foreign issuerFeb 18, 2025Current reportSEC
6-K · Report of a foreign issuerJan 27, 2025Current reportSEC
6-K · Report of a foreign issuerDec 23, 2024Current reportSEC
6-K · Report of a foreign issuerNov 13, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedNov 6, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerNov 4, 2024Current reportSEC
6-K · Report of a foreign issuerOct 22, 2024Current reportSEC
6-K · Report of a foreign issuerOct 10, 2024Current reportSEC
EFFECT · Notice that a registration is effectiveAug 30, 2024Other filingsSEC
424B3 · ProspectusAug 29, 2024Offer documentSEC
CORRESP · Letter to the SECAug 27, 2024Other filingsSEC
UPLOAD · Letter from the SECAug 23, 2024Other filingsSEC
F-3 · Registration statementAug 21, 2024Offer documentSEC
6-K · Report of a foreign issuerAug 15, 2024Current reportSEC
6-K · Report of a foreign issuerAug 15, 2024Current reportSEC
6-K · Report of a foreign issuerJul 22, 2024Current reportSEC
6-K · Report of a foreign issuerJul 11, 2024Current reportSEC
SC 13D/A · Big-stake notice, amendedJul 3, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerJul 2, 2024Current reportSEC
6-K · Report of a foreign issuerJul 2, 2024Current reportSEC
6-K/A · Report of a foreign issuer, amendedJul 1, 2024Current reportSEC
6-K · Report of a foreign issuerJul 1, 2024Current reportSEC
RW · Request to withdraw a registrationJun 26, 2024Other filingsSEC
6-K · Report of a foreign issuerJun 26, 2024Current reportSEC
6-K · Report of a foreign issuerJun 18, 2024Current reportSEC
6-K · Report of a foreign issuerJun 14, 2024Current reportSEC
424B5 · ProspectusJun 14, 2024Offer documentSEC
6-K · Report of a foreign issuerJun 11, 2024Current reportSEC
6-K · Report of a foreign issuerJun 11, 2024Current reportSEC
6-K · Report of a foreign issuerJun 7, 2024Current reportSEC
6-K · Report of a foreign issuerMay 22, 2024Current reportSEC
6-K · Report of a foreign issuerMay 21, 2024Current reportSEC
6-K · Report of a foreign issuerMay 21, 2024Current reportSEC
6-K · Report of a foreign issuerApr 30, 2024Current reportSEC
6-K · Report of a foreign issuerApr 25, 2024Current reportSEC
6-K · Report of a foreign issuerApr 19, 2024Current reportSEC
6-K · Report of a foreign issuerApr 16, 2024Current reportSEC
6-K · Report of a foreign issuerMar 22, 2024Current reportSEC
20-F · Annual reportMar 20, 2024Annual reportSEC
6-K · Report of a foreign issuerMar 20, 2024Current reportSEC
6-K · Report of a foreign issuerMar 1, 2024Current reportSEC
6-K · Report of a foreign issuerFeb 26, 2024Current reportSEC
6-K · Report of a foreign issuerFeb 23, 2024Current reportSEC
6-K · Report of a foreign issuerFeb 15, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerJan 29, 2024Current reportSEC
6-K · Report of a foreign issuerJan 19, 2024Current reportSEC
6-K · Report of a foreign issuerJan 10, 2024Current reportSEC
6-K · Report of a foreign issuerJan 3, 2024Current reportSEC
6-K/A · Report of a foreign issuer, amendedNov 30, 2023Current reportSEC
6-K · Report of a foreign issuerNov 29, 2023Current reportSEC
6-K · Report of a foreign issuerNov 29, 2023Current reportSEC
6-K · Report of a foreign issuerNov 15, 2023Current reportSEC
6-K · Report of a foreign issuerNov 14, 2023Current reportSEC
6-K · Report of a foreign issuerNov 13, 2023Current reportSEC
EFFECT · Notice that a registration is effectiveOct 31, 2023Other filingsSEC
CORRESP · Letter to the SECOct 27, 2023Other filingsSEC
UPLOAD · Letter from the SECOct 26, 2023Other filingsSEC
F-3 · Registration statementOct 20, 2023Offer documentSEC
6-K · Report of a foreign issuerOct 12, 2023Current reportSEC
6-K · Report of a foreign issuerOct 3, 2023Current reportSEC
6-K · Report of a foreign issuerSep 25, 2023Current reportSEC
6-K · Report of a foreign issuerSep 21, 2023Current reportSEC
6-K/A · Report of a foreign issuer, amendedSep 7, 2023Current reportSEC
6-K · Report of a foreign issuerSep 5, 2023Current reportSEC
6-K · Report of a foreign issuerAug 31, 2023Current reportSEC
6-K · Report of a foreign issuerAug 1, 2023Current reportSEC
6-K · Report of a foreign issuerJul 24, 2023Current reportSEC
424B3 · ProspectusJul 24, 2023Offer documentSEC
424B3 · ProspectusJul 24, 2023Offer documentSEC
EFFECT · Notice that a registration is effectiveJul 24, 2023Other filingsSEC
EFFECT · Notice that a registration is effectiveJul 21, 2023Other filingsSEC
CORRESP · Letter to the SECJul 20, 2023Other filingsSEC
UPLOAD · Letter from the SECJul 20, 2023Other filingsSEC
F-3 · Registration statementJul 14, 2023Offer documentSEC
POS AM · Amendment to an effective registrationJul 14, 2023Offer documentSEC
6-K · Report of a foreign issuerJul 12, 2023Current reportSEC
424B3 · ProspectusJun 29, 2023Offer documentSEC
6-K · Report of a foreign issuerJun 29, 2023Current reportSEC
6-K · Report of a foreign issuerJun 13, 2023Current reportSEC
424B3 · ProspectusJun 6, 2023Offer documentSEC
6-K · Report of a foreign issuerJun 6, 2023Current reportSEC
424B3 · ProspectusMay 24, 2023Offer documentSEC
6-K · Report of a foreign issuerMay 24, 2023Current reportSEC
6-K · Report of a foreign issuerMay 19, 2023Current reportSEC
6-K · Report of a foreign issuerMay 5, 2023Current reportSEC
6-K · Report of a foreign issuerMay 4, 2023Current reportSEC
6-K · Report of a foreign issuerApr 19, 2023Current reportSEC
6-K · Report of a foreign issuerApr 17, 2023Current reportSEC
424B3 · ProspectusApr 14, 2023Offer documentSEC
6-K · Report of a foreign issuerApr 14, 2023Current reportSEC
6-K · Report of a foreign issuerMar 28, 2023Current reportSEC
EFFECT · Notice that a registration is effectiveMar 17, 2023Other filingsSEC
POS AM · Amendment to an effective registrationMar 13, 2023Offer documentSEC
20-F · Annual reportMar 1, 2023Annual reportSEC
6-K · Report of a foreign issuerMar 1, 2023Current reportSEC
SC 13G · Big-stake noticeFeb 14, 2023Big-stake noticeSEC
424B3 · ProspectusFeb 10, 2023Offer documentSEC
424B3 · ProspectusFeb 10, 2023Offer documentSEC
6-K · Report of a foreign issuerFeb 10, 2023Current reportSEC
424B3 · ProspectusFeb 9, 2023Offer documentSEC
424B3 · ProspectusFeb 9, 2023Offer documentSEC
6-K · Report of a foreign issuerFeb 9, 2023Current reportSEC
6-K · Report of a foreign issuerFeb 7, 2023Current reportSEC
6-K · Report of a foreign issuerFeb 7, 2023Current reportSEC
6-K · Report of a foreign issuerJan 24, 2023Current reportSEC
424B3 · ProspectusJan 23, 2023Offer documentSEC
424B3 · ProspectusJan 23, 2023Offer documentSEC
6-K · Report of a foreign issuerJan 23, 2023Current reportSEC
6-K · Report of a foreign issuerJan 20, 2023Current reportSEC
6-K · Report of a foreign issuerJan 17, 2023Current reportSEC
424B3 · ProspectusJan 11, 2023Offer documentSEC
424B3 · ProspectusJan 11, 2023Offer documentSEC
6-K · Report of a foreign issuerJan 11, 2023Current reportSEC
424B3 · ProspectusJan 6, 2023Offer documentSEC
424B3 · ProspectusJan 6, 2023Offer documentSEC
6-K · Report of a foreign issuerJan 6, 2023Current reportSEC
424B3 · ProspectusDec 22, 2022Offer documentSEC
424B3 · ProspectusDec 22, 2022Offer documentSEC
6-K · Report of a foreign issuerDec 22, 2022Current reportSEC
424B3 · ProspectusDec 16, 2022Offer documentSEC
424B3 · ProspectusDec 16, 2022Offer documentSEC
6-K · Report of a foreign issuerDec 16, 2022Current reportSEC
424B3 · ProspectusDec 8, 2022Offer documentSEC
424B3 · ProspectusDec 8, 2022Offer documentSEC
6-K · Report of a foreign issuerDec 8, 2022Current reportSEC
424B3 · ProspectusDec 1, 2022Offer documentSEC

This page holds 200 of 304 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Alvotech’s releases · as of Jun 18, 2026

Common shares
356,817,038
Fully diluted
356,817,038

Fully diluted

LineShares
Common shares356,817,038

Share count over time

CountShares
Nov 22, 2026356,817,038

Open Cap table

Shareholders

HolderSharesValueAs of
Vanguard Total International Stock Index Fund1.67MUS$6.45MJul 31, 2026
Vanguard Emerging Markets Stock Index Fund1.61MUS$6.22MJul 31, 2026
T. Rowe Price International Discovery Fund1.12MUS$4.62MJul 31, 2026
iShares Biotechnology ETF839KUS$3.1MJun 30, 2026
Global Macro Absolute Return Advantage Portfolio593KUS$2.29MJul 31, 2026
Royce Smaller-Companies Growth Fund524KUS$1.93MJun 30, 2026
Vanguard Ftse All-World Ex-Us Index Fund257KUS$993KJul 31, 2026
iShares Genomics Immunology and Healthcare ETF245KUS$1.01MJul 31, 2026
Fidelity Nasdaq Composite Index Fund201KUS$674KMay 31, 2026
Global Macro Portfolio160KUS$616KJul 31, 2026
All 25 holders
HolderSharesValueAs of
Schwab Emerging Markets Equity ETF133KUS$460KMay 31, 2026
Fidelity Nasdaq Composite Index ETF131KUS$441KMay 31, 2026
Vanguard Total World Stock Index Fund125KUS$481KJul 31, 2026
Invesco RAFI US 1500 Small-Mid ETF73,335US$302KJul 31, 2026
Parametric Emerging Markets Fund66,700US$275KJul 31, 2026
Vanguard ESG International Stock ETF22,471US$77,184May 31, 2026
Invesco Nasdaq Biotechnology ETF17,707US$59,496May 31, 2026
GlacierShares Nasdaq Iceland ETF17,271US$63,730Jun 30, 2026
ProShares Ultra Nasdaq Biotechnology12,210US$41,026May 31, 2026
Parametric Tax-Managed Emerging Markets Fund9,000US$33,210Jun 30, 2026
Total Stock Market Index Trust5,090US$18,782Jun 30, 2026
T. Rowe Price Global Allocation Fund4,454US$18,350Jul 31, 2026
Vanguard Emerging Markets Ex-China ETF3,275US$11,249May 31, 2026
T. Rowe Price International Equity Research ETF1,613US$6,646Jul 31, 2026
Knights of Columbus U.S. ALL CAP INDEX FUND670US$2,760Jul 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
ALVOTECHBenedikt StefanssonVP Investor Relations and Global · Oct 6, 2025 – Nov 5, 2026 · Past
Anthony M. MaffiaChief Quality and Regulatory Affairs Officer · Since at least Mar 18, 2026
Balaji V. PrasadChief Strategy Officer · Since at least Mar 27, 2025
Benedikt StefanssonVP Investor Relations and Global Communications IS · Since at least Dec 31, 2025
CommunicationsBenedikt StefanssonVP Global Communications and Investor · Sep 19, 2025 – Nov 5, 2026 · Past
Joseph E. McClellanChief Operating Officer · Since at least Oct 20, 2026
Kathryn GunnarssonSVP Global Talent & People Experience · Since at least Nov 5, 2026
Linda JónsdóttirChief Financial Officer · Since at least Jul 10, 2025
Lisa GraverChief Executive Officer · Since at least Jan 6, 2026
MediaBenedikt StefanssonVP Investor Relations and Global CommunicationsSarah Macleod, Head of Global · Since at least Dec 31, 2025
All 13 people
PersonSeat
Neha PatelChief Information Officer · Since at least Nov 5, 2026
Patrik LingVP of Investor Relations Scandinavia · Since at least Aug 20, 2025
Robert WessmanExecutive Chairman · Since at least Nov 2, 2026

Open People

Log in to ask 6ix AI your own questions about Alvotech.